8
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prevalencia de sobrepeso/obesidad y su asociación con diabetes, hipertensión, dislipemia y síndrome metabólico: estudio transversal de una muestra de trabajadores en Aragón, España Translated title: Prevalence of overweight/obesity and its association with diabetes, hypertension, dyslipidemia and metabolic syndrome: a cross-sectional study of a sample of workers in Aragón, Spain

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Resumen Objetivos: estimar la prevalencia de sobrepeso y obesidad en una muestra de trabajadores en Aragón (España) y cuantificar su asociación con la prevalencia de diabetes, dislipemia, hipertensión arterial y síndrome metabólico. Métodos: estudio descriptivo transversal sobre una muestra de 23.729 trabajadores. Se utilizaron los datos de las revisiones médicas rutinarias (exploración física, analítica sanguínea y cuestionario estructurado) practicadas por MAS Sociedad de Prevención. Resultados: la prevalencia de sobrepeso fue del 38,6% y la de obesidad, del 18,4%, siendo superiores en los varones. La prevalencia de diabetes mellitus, hipertensión, dislipemia y síndrome metabólico fue de 7,6%, 20,1%, 31,3% y 7,5%, respectivamente. Se observó una asociación significativa entre el sobrepeso y la obesidad y la prevalencia de diabetes, dislipemia, hipertensión y síndrome metabólico. Conclusiones: los estados de sobrepeso y obesidad son comunes en la población trabajadora y se relacionan con un importante aumento de la prevalencia de factores de riesgo cardiovascular. Es necesario promover estrategias de prevención y manejo del peso corporal en la población trabajadora.

          Translated abstract

          Abstract Objectives: to estimate the prevalence of overweight and obesity in a sample of workers in Aragón (Spain) and to assess its associations with diabetes, dyslipidemia, hypertension and metabolic syndrome. Methods: cross-sectional study of a sample of 23,729 workers. Data from routine medical check-ups (physical examination, blood analysis and structured questionnaire) practiced by MAS Sociedad de Prevención were used. Results: prevalence of overweight and obesity was 38.6% and 18.4%, respectively (higher in males). Prevalence of diabetes mellitus, hypertension, dyslipidemia and metabolic syndrome was 7.6%, 20.1%, 31.3% and 7.5%, respectively. There was a significant association between overweight and obesity and prevalence of diabetes, dyslipidemia, hypertension and metabolic syndrome. Conclusions: states of overweight and obesity are common in the working population and are related to a significant increase in the prevalence of cardiovascular risk factors. It is necessary to promote strategies for prevention and management of body weight in the working population.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          The medical care costs of obesity: an instrumental variables approach.

          This paper is the first to use the method of instrumental variables (IV) to estimate the impact of obesity on medical costs in order to address the endogeneity of weight and to reduce the bias from reporting error in weight. Models are estimated using restricted-use data from the Medical Expenditure Panel Survey for 2000-2005. The IV model, which exploits genetic variation in weight as a natural experiment, yields estimates of the impact of obesity on medical costs that are considerably higher than the estimates reported in the previous literature. For example, obesity is associated with $656 higher annual medical care costs, but the IV results indicate that obesity raises annual medical costs by $2741 (in 2005 dollars). These results imply that the previous literature has underestimated the medical costs of obesity, resulting in underestimates of the economic rationale for government intervention to reduce obesity-related externalities. Copyright © 2011 Elsevier B.V. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mediterranean diet and cardiovascular health: Teachings of the PREDIMED study.

            The PREDIMED (Prevención con Dieta Mediterránea) study was designed to assess the long-term effects of the Mediterranean diet (MeDiet) without any energy restriction on incident cardiovascular disease (CVD) as a multicenter, randomized, primary prevention trial in individuals at high risk. Participants were randomly assigned to 3 diet groups: 1) MeDiet supplemented with extra-virgin olive oil (EVOO); 2) MeDiet supplemented with nuts; and 3) control diet (advice on a low-fat diet). After 4.8 y, 288 major CVD events occurred in 7447 participants; crude hazard ratios were 0.70 (95% CI: 0.53, 0.91) for the MeDiet + EVOO and 0.70 (95% CI: 0.53, 0.94) for the MeDiet + nuts compared with the control group. Respective hazard ratios for incident diabetes (273 cases) among 3541 participants without diabetes were 0.60 (95% CI: 0.43, 0.85) and 0.82 (95% CI: 0.61, 1.10) compared with the control group. After 1-y follow-up, participants in the MeDiet + nuts group showed a significant 13.7% reduction in prevalence of metabolic syndrome compared with reductions of 6.7% and 2.0% in the MeDiet + EVOO and control groups, respectively. Analyses of intermediate markers of cardiovascular risk demonstrated beneficial effects of the MeDiets on blood pressure, lipid profiles, lipoprotein particles, inflammation, oxidative stress, and carotid atherosclerosis, as well as on the expression of proatherogenic genes involved in vascular events and thrombosis. Nutritional genomics studies demonstrated interactions between a MeDiet and cyclooxygenase-2 (COX-2), interleukin-6 (IL-6), apolipoprotein A2 (APOA2), cholesteryl ester transfer protein plasma (CETP), and transcription factor 7-like 2 (TCF7L2) gene polymorphisms. The PREDIMED study results demonstrate that a high-unsaturated fat and antioxidant-rich dietary pattern such as the MeDiet is a useful tool in the prevention of CVD.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Prevalencia de obesidad general y obesidad abdominal en la población adulta española (25–64 años) 2014–2015: estudio ENPE

                Bookmark

                Author and article information

                Contributors
                Role: ND
                Role: ND
                Role: ND
                Role: ND
                Role: ND
                Role: ND
                Role: ND
                Role: ND
                Journal
                nh
                Nutrición Hospitalaria
                Nutr. Hosp.
                Grupo Arán (Madrid, Madrid, Spain )
                0212-1611
                1699-5198
                February 2019
                : 36
                : 1
                : 51-59
                Affiliations
                [2] Zaragoza orgnameMAS Prevención orgdiv1Servicio de Prevención Spain
                [1] Villanueva de Gállego, Zaragoza Aragón orgnameUniversidad San Jorge Spain
                Article
                S0212-16112019000100051
                10.20960/nh.1980
                30834762
                e3d2f7c9-cd4f-41a6-b05a-b7114471de21

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

                History
                : 10 April 2018
                : 16 May 2018
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 37, Pages: 9
                Product

                SciELO Spain

                Categories
                Trabajos Originales

                Hypertension,Sobrepeso,Obesidad,Diabetes mellitus,Hipertensión,Dislipemias,Síndrome metabólico,Overweight,Obesity,Dyslipidemia,Metabolic syndrome

                Comments

                Comment on this article